European Companies Search Engine
Member of the Executive Board: Ugur Sahin · No longer Member of the Executive Board (1) · Address · Capital: €74,637 · Name: BioNTech AG · Company statute · Corporate Purpose Hrb 15 Dec 2008 German Trade Register Announcements, Germany (11/12/2008)
Overview
Text
Petersberg 91. V V AG,
Unnamed street ??, 53113 Bonn, Germany
. The Annual General Meeting of January 10, 2008 decided to increase the share capital against cash deposits by EUR 24,637.00 and to amend Section 4 of the Articles of Association (height and division of the share capital). The capital increase has been carried out. The statutes are completely recast. In particular, the following provisions have been amended: Sections 1 (1) (Company) and Section 2 (object of the company). New company: BioNTech AG. Additionally registered: Business address:
Unnamed street ??, 53113 Bonn, Germany
. New corporate object: the research and development of immunological drugs and test methods for the diagnosis, prevention and treatment of cancers. New share capital: EUR 74,637.00. Board of Directors: Prof. Dr. Sahin, Ugur, Mainz, *??.??.???? to enter into legal transactions with the authority to enter into legal transactions on behalf of the company a.s. a representative of a third party. No longer a board member: ???????????, ??????, Worms, *??.??.????.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: BioNTech AG, Mainz, Germany.